266 related articles for article (PubMed ID: 17982733)
1. Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.
Rahimi Z; Ghaderi M; Nagel RL; Muniz A
J Thromb Thrombolysis; 2008 Dec; 26(3):229-33. PubMed ID: 17982733
[TBL] [Abstract][Full Text] [Related]
2. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.
Al-Sweedan SA; Jaradat S; Iraqi M; Beshtawi M
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):675-8. PubMed ID: 19710606
[TBL] [Abstract][Full Text] [Related]
4. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
[TBL] [Abstract][Full Text] [Related]
5. Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-beta-0 thalassemia patients.
Isma'eel H; Arnaout MS; Shamseddeen W; Mahfouz R; Zeineh N; Jradi O; Taher A
J Thromb Thrombolysis; 2006 Oct; 22(2):121-3. PubMed ID: 17008978
[TBL] [Abstract][Full Text] [Related]
6. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
[TBL] [Abstract][Full Text] [Related]
7. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
[TBL] [Abstract][Full Text] [Related]
8. Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos.
Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ramírez-Cisneros FJ
Am J Hematol; 2001 Jan; 66(1):28-31. PubMed ID: 11426488
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
[TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.
Belhaj Nefissi R; Doggui R; Ouali F; Messaoud T; Gritli N
Hemoglobin; 2018 Mar; 42(2):96-102. PubMed ID: 30200836
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
Eid SS; Rihani G
Clin Lab Sci; 2004; 17(4):200-2. PubMed ID: 15559724
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.
Rahimi Z; Vaisi-Raygani A; Mozafari H; Kharrazi H; Rezaei M; Nagel RL
J Thromb Thrombolysis; 2008 Jun; 25(3):280-3. PubMed ID: 17700999
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T among G6PD deficient individuals from Western Iran.
Mozafari H; Rahimi Z; Heidarpour A; Fallahi M; Muniz A
Mol Biol Rep; 2009 Nov; 36(8):2361-4. PubMed ID: 19219640
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of factor V Leiden G1691A, MTHFR C677T, and prothrombin G20210A among Asian Indian sickle cell patients.
Pandey SK; Meena A; Kishor K; Mishra RM; Pandey S; Saxena R
Clin Appl Thromb Hemost; 2012 Jun; 18(3):320-3. PubMed ID: 22084413
[TBL] [Abstract][Full Text] [Related]
17. Frequency of three prothrombotic polymorphisms among Syrian population: factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase C677T.
Jarjour RA; Ammar S; Majdalawi R
Ann Hum Biol; 2017 Feb; 44(1):70-73. PubMed ID: 26560857
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.
Aydin H; Gunay M; Celik G; Gunay BO; Aydin UT; Karaman A
Ophthalmic Genet; 2016 Dec; 37(4):415-418. PubMed ID: 27018927
[TBL] [Abstract][Full Text] [Related]
19. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
Almawi WY; Ameen G; Tamim H; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
[TBL] [Abstract][Full Text] [Related]
20. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]